Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,546 | 23,872 | 27,273 | 28,024 | 31,807 |
| Receivables | 7,344 | 8,471 | 4,704 | 12,120 | 6,955 |
| Inventories | 6,044 | 6,769 | 5,780 | 4,038 | 2,461 |
| TOTAL | $88,220 | $40,966 | $39,888 | $47,259 | $44,625 |
| Non-Current Assets | |||||
| PPE Net | 3,799 | 4,179 | 4,085 | 5,055 | 6,873 |
| Intangibles | 0 | 1,278 | 1,435 | 51 | 102 |
| Other Non-Current Assets | 9,405 | 10,995 | 11,662 | 9,628 | 11,284 |
| TOTAL | $13,204 | $16,452 | $17,182 | $14,734 | $18,259 |
| Total Assets | $101,424 | $57,418 | $57,070 | $61,993 | $62,884 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,313 | 8,948 | 9,946 | 10,339 | 9,664 |
| Accrued Expenses | 5,907 | 6,497 | 7,967 | 8,736 | 8,569 |
| Other current liabilities | 1,087 | 922 | 1,147 | 1,225 | 1,450 |
| TOTAL | $18,865 | $18,308 | $39,528 | $21,964 | $21,104 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,500 | 27,508 | 33,448 | 51,551 | 34,329 |
| Deferred Revenues | 1,048 | 1,551 | 1,513 | 765 | 693 |
| aiOther Non-Current Liabilities | 90,210 | 85,744 | 71,231 | 63,490 | 52,315 |
| TOTAL | $142,715 | $145,597 | $136,096 | $122,163 | $90,277 |
| Total Liabilities | $161,580 | $163,905 | $175,624 | $144,127 | $111,381 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 98,871 | 73,301 | 55,871 | 41,468 | 36,214 |
| Common Shares | 91 | 69 | 55 | 41 | 35 |
| Retained earnings | -363,214 | -319,077 | -311,207 | -256,796 | -186,257 |
| TOTAL | $-60,156 | $-106,487 | $-118,554 | $-82,134 | $-48,497 |
| Total Liabilities And Equity | $101,424 | $57,418 | $57,070 | $61,993 | $62,884 |